Thaker G K, Wagman A M, Kirkpatrick B, Tamminga C A
Maryland Psychiatric Research Center, Department of Psychiatry, School of Medicine, University of Maryland, Baltimore 21228.
Biol Psychiatry. 1989 Jan;25(1):75-86. doi: 10.1016/0006-3223(89)90149-2.
Although a number of studies have reported sleep disturbances following neuroleptic withdrawal, a full description of such changes in sleep architecture is not available. Polysomnographic, plasma prolactin, and clinical measurements were carried out in a small number of patients on chronic neuroleptic treatment and after drug withdrawal. Preliminary findings show that in these chronically treated schizophrenic patients with and without tardive dyskinesia (TD), abrupt neuroleptic withdrawal induces reductions in total sleep, rapid eye movement (REM) sleep, and plasma prolactin. Furthermore, an increase in delta sleep was observed only in patients without TD. The REM suppression occurred significantly earlier in TD patients compared to the non-TD schizophrenic patients. These changes were transient, and both sleep measures and plasma prolactin stabilized during the 2-4 weeks after withdrawal to levels somewhere between the values observed during chronic treatment and withdrawal (week 1) periods. As the withdrawal-induced exaggerated changes mimicked the dopamine agonist effect on these sleep and hormonal measures, one can hypothesize that the observed changes are due to unmasking of supersensitive dopamine receptors following drug cessation. Normalization of these receptors and/or adaptational changes in other nondopaminergic system(s) can hypothetically explain the eventual stabilization of these measures during the following weeks.
尽管已有多项研究报道了停用抗精神病药物后出现的睡眠障碍,但目前尚无关于睡眠结构此类变化的完整描述。对少数接受慢性抗精神病药物治疗的患者以及停药后进行了多导睡眠图、血浆催乳素和临床测量。初步研究结果表明,在这些患有或未患有迟发性运动障碍(TD)的慢性治疗精神分裂症患者中,突然停用抗精神病药物会导致总睡眠时间、快速眼动(REM)睡眠和血浆催乳素减少。此外,仅在未患TD的患者中观察到δ睡眠增加。与未患TD的精神分裂症患者相比,TD患者的REM抑制出现得明显更早。这些变化是短暂的,在停药后的2至4周内,睡眠指标和血浆催乳素均稳定在慢性治疗期和停药(第1周)期所观察到的值之间的某个水平。由于停药引起的过度变化类似于多巴胺激动剂对这些睡眠和激素指标的影响,因此可以推测观察到的变化是由于停药后超敏多巴胺受体的暴露所致。假设这些受体的正常化和/或其他非多巴胺能系统的适应性变化可以解释接下来几周内这些指标的最终稳定。